Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
BioInvent
-
search results
If you're not happy with the results, please do another search
BioInvent’s CMO comments on the ESMO presentation
16 September, 2024
BioInvent makes a strong entrance at ESMO in Barcelona
13 September, 2024
BioInvent anticipates a continued data-rich 2024
2 September, 2024
BioInvent and MSD to evaluate new metastatic melanoma treatment
19 July, 2024
Top oncologist underscores BioInvent’s potential for “Immunotherapy 2.0”
1 July, 2024
BioInvent to present promising clinical data at ASCO and EHA
30 May, 2024
BioInvent selected to present at ASCO in Chicago
29 April, 2024
BioInvent deepens collaboration with MSD
4 April, 2024
BioInvent’s CEO comments on the study success in China
11 March, 2024
BioInvent expects data from seven clinical studies in 2024
18 January, 2024
BioInvent’s CEO: “This year we made unprecedented progress”
21 December, 2023
BioInvent comments on breast cancer study progress
13 December, 2023
BioInvent is gearing up for clinical data presentations
31 October, 2023
All sessions from BioStock Life Science Fall Summit 2023
30 October, 2023
Video from day 2 of BioStock Life Science Fall Summit 2023
27 October, 2023
BioInvent achieves research milestone in partnership with Exelixis
8 September, 2023
BioInvent soon has five drug candidates in six clinical studies
1 September, 2023
BioInvent’s CMO comments on phase I/IIa data with BI-1808
27 June, 2023
BioInvent ready for combination studies with BT-001
5 June, 2023
The BioStock Life Science Spring Summit 2023 goes live today
30 May, 2023
BioInvent’s CFO on the company’s business strategy
9 May, 2023
BioInvent reports clinical progress with BI-1206
21 April, 2023
BioInvent’s CEO expects eventful 2023
1 March, 2023
BioStock Life Science Summit 2023
22 February, 2023
CMO gives insight on new BioInvent collaboration
25 January, 2023
Watch the BioStock Life Science Fall Summit!
8 December, 2022
Can Nordic companies extend the life of Keytruda?
1 December, 2022
Regulatory success for BioInvent in the US
21 November, 2022
Strengthened finances and clinical progress for BioInvent in Q3
2 November, 2022
BioInvent reaches milestone for BI-1808
8 September, 2022
BioInvent sums up eventful Q2
29 August, 2022
BioStock Life Science Fall Summit 2022
16 August, 2022
BioInvent and CASI on their collaboration
23 June, 2022
BioInvent in new potentially lucrative license agreement
22 June, 2022
Bioinvent shifts into higher gear
5 May, 2022
BioInvent presents several projects at AACR’s annual meeting
11 March, 2022
BioInvent delivers in 2021; more to come in 2022
25 February, 2022
BioInvent strengthens the organisation with COO
1 February, 2022
BioInvent’s CMO on the positive FDA decision
21 January, 2022
BioInvent presents additional positive study data
21 December, 2021
BioInvent presents positive interim data
14 December, 2021
BioInvent’s CMO on new positive data with BI-1206
12 November, 2021
BioInvent offers guidance on upcoming milestones
3 November, 2021
Eight CEOs on their expectations at BIO-Europe
25 October, 2021
Join us for the BioStock Life Science Summit on October 20...
20 October, 2021
BioInvent’s CEO on the benefits of a diversified portfolio
28 September, 2021
Bauerfeind AG loan signals confidence in Xintela
6 July, 2021
Xintela advances on several fronts
6 July, 2021
Innovation in focus at BioStock Life Science Spring Summit 2021
25 May, 2021
